Medication info

Chacotrace Injection (Activated Charcoal)

Prescription medicationInjectionsApproval revoked
Ingredient · strength
Medicinal Carbon›40mg / 1mL
Manufacturer / importer
Jaytech pharm Inc.
Appearance
An opaque black liquid in a colorless transparent vial, formulated as a suspension for injection.
Packaging
Vial - 3 milliliters/vial
Approval status
Approval revoked

MFDS item code 202107557 · Approved 2021.11.18

This product's status changed to Approval revoked on 2024.02.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Adjunct to surgery by marking the site of a nonpalpable breast tumor
Who uses it
Adults
Adult dosage
Using a breast stereotactic device or ultrasound, identify the tumor site to be removed. Using an 18-gauge needle, inject this product (approximately 0.3~1mL) subcutaneously at the site, and slowly withdraw the needle while moving it back and forth to create a clearly visible track. Keep the syringe barrel horizontal during injection. Use only the minimum amount needed for marking; do not administer more than 1mL. Do not reuse the opened product.

Ingredients

Importer
Jaytech pharm Inc.

Efficacy & effects

Adjunct to surgery by marking the site of a nonpalpable breast tumor

View approved original text

This is a surgical auxiliary agent that helps to mark small areas that cannot be felt by hand during breast tumor excision surgery, utilizing localization devices or ultrasound. This drug assists in accurately locating the areas and increases the safety and precision of the surgery. As a result, it makes it possible to clearly identify the tumor site during surgery for effective removal. Such surgical auxiliaries contribute to patient recovery and reduce recurrence rates.

Dosage and Administration

Adult dosage

Using a breast stereotactic device or ultrasound, identify the tumor site to be removed. Using an 18-gauge needle, inject this product (approximately 0.3~1mL) subcutaneously at the site, and slowly withdraw the needle while moving it back and forth to create a clearly visible track. Keep the syringe barrel horizontal during injection. Use only the minimum amount needed for marking; do not administer more than 1mL. Do not reuse the opened product.

Precautions

This drug should only be used by trained physicians and must be accurately marked only on the tumor area to be removed during surgery. All marked areas during surgery must be completely removed, and if not removed and left in the body for more than 6 months, inflammatory or immune reactions may occur. This drug should not be administered to patients with hypersensitivity to activated charcoal or dyes, or to pregnant or breastfeeding women. After use, side effects such as pain or a prickling sensation in the breast area, swelling, fever, or redness at the injection site may occur. This drug should only be injected subcutaneously and must not be administered by any other route. It should be used only when there is a clear surgical plan and only at the site of breast lesions. Administering beyond the necessary amount may cause the drug to spread to other tissues beyond the injection area. Ensure that the vial is shaken well before use as activated charcoal particles may block the needle, and injection should not be performed with excessive pressure. No safety studies have been conducted in pregnant women, nor has any research been done regarding use during breastfeeding. This drug is for single use only, and any remaining drug must be discarded. It should be stored out of reach of children. High doses administered intravenously may lead to pulmonary vessel accumulation of the drug, resulting in respiratory distress, therefore intravenous administration should be avoided.

Side effects

  • Chest pain
  • stabbing tingling
  • swelling at the injection site
  • fever
  • redness
  • pain
  • granuloma
  • immunological bodily response

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may lose its effectiveness if exposed to air or moisture, so it must be stored in a sealed container. The storage temperature should be kept between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

An opaque black liquid in a colorless transparent vial, formulated as a suspension for injection.

Package unit

Vial - 3 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.